218 related articles for article (PubMed ID: 7808958)
1. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
2. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
Skomra S; Przybylska T
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
[TBL] [Abstract][Full Text] [Related]
3. Acute haemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukaemia --a case report.
Tan CL; Chiang SP; Wee KP
Singapore Med J; 1974 Dec; 15(4):278-82. PubMed ID: 4533158
[No Abstract] [Full Text] [Related]
4. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia.
Semeraro N; Montemurro P; Giordano P; Schettini F; Santoro N; De Mattia D; Giordano D; Conese M; Colucci M
Thromb Haemost; 1990 Aug; 64(1):38-40. PubMed ID: 2274927
[TBL] [Abstract][Full Text] [Related]
5. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
Billett AL; Carls A; Gelber RD; Sallan SE
Cancer; 1992 Jul; 70(1):201-6. PubMed ID: 1606543
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experiences with adrenaline as therapy and prevention of E. coli-L-asparaginase-induced anaphylaxis].
Schwinger W; Urban C; Lackner H
Klin Padiatr; 1992; 204(4):274-6. PubMed ID: 1518264
[TBL] [Abstract][Full Text] [Related]
7. Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia.
Brueck M; Koerholz D; Nuernberger W; Juergens H; Goebel U; Wahn V
Dev Pharmacol Ther; 1989; 12(4):200-4. PubMed ID: 2504568
[TBL] [Abstract][Full Text] [Related]
8. [Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies].
Körholz D; Wahn U; Jürgens H; Wahn V
Monatsschr Kinderheilkd; 1990 Jan; 138(1):23-5. PubMed ID: 2314401
[TBL] [Abstract][Full Text] [Related]
9. [Pancreatic pseudocyst. A case report and review of the literature].
Beteta-Chinchilla CE; Flores-Calderón J; Ramírez-Mayans JA; Casaubón-Garcín P; Mora-Tiscareño MA
Bol Med Hosp Infant Mex; 1991 Jun; 48(6):445-52. PubMed ID: 1910561
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
Nesbit M; Chard R; Evans A; Karon M; Hammond GD
Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
[TBL] [Abstract][Full Text] [Related]
11. Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia.
Eden OB; Shaw MP; Lilleyman JS; Richards S
Med Pediatr Oncol; 1990; 18(6):497-502. PubMed ID: 2233523
[TBL] [Abstract][Full Text] [Related]
12. Children With Asparaginase-associated Pancreatitis Present Elevated Levels of Insulin, Total Cholesterol, and HOMA-IR Before Starting Acute Lymphoblastic Leukemia Treatment.
Chávez-Aguilar LA; Ávila-Castro D; Merino-Pasaye LE; Peña-Vélez R
J Pediatr Hematol Oncol; 2022 Aug; 44(6):342-344. PubMed ID: 34966097
[TBL] [Abstract][Full Text] [Related]
13. Trypsin-encoding
Wolthers BO; Frandsen TL; Patel CJ; Abaji R; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grosjean M; Krajinovic M; Larsen E; Liang DC; Möricke A; Rasmussen KK; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Tulstrup M; Yadav R; Yang W; Zapotocka E; Gupta R; Schmiegelow K;
Haematologica; 2019 Mar; 104(3):556-563. PubMed ID: 30467200
[TBL] [Abstract][Full Text] [Related]
14. [Delayed acute pancreatitis after treatment with L-asparaginase. A case report].
Pecquenard L; Damay M; Naveau C; Lemarchand V; Dufay E; Berod T
Therapie; 1990; 45(5):453-4. PubMed ID: 2260047
[No Abstract] [Full Text] [Related]
15. A comparison of hypersensitivity reactions between intravenous and intramuscular applications of native
Odaman Al I; Özdemir N; Zengin Ersoy G; Bayram C; Vupa Çilengiroğlu Ö; Arslantaş E; Paslı Uysalol E; Ayçiçek A
J Oncol Pharm Pract; 2023 Sep; 29(6):1454-1460. PubMed ID: 36942380
[TBL] [Abstract][Full Text] [Related]
16. [Results of repeated L-asparaginase treatment in acute lymphoblastic leukemia and lymphosarcoma in children].
Zajaczkowski J; Legutko L; Armata J; Halikowska-łacka E
Pediatr Pol; 1975 Aug; 50(8):985-90. PubMed ID: 1057762
[No Abstract] [Full Text] [Related]
17. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
Zajaczkowski J; Pituch A; Legutko L; Pajak E
Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
[TBL] [Abstract][Full Text] [Related]
18. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
Murakawa M; Okamura T; Shibuya T; Harada M; Otsuka T; Niho Y
Ann Hematol; 1992 May; 64(5):249-52. PubMed ID: 1623061
[TBL] [Abstract][Full Text] [Related]
19. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
[No Abstract] [Full Text] [Related]
20. [Delayed hypersensitivity reaction caused by asparaginase].
Couselo JM; Iglesias Diz JL
An Esp Pediatr; 1988 Oct; 29 Suppl 34():153-4. PubMed ID: 3214028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
